Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects-Reference-Cited by-同舟云学术

Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects

Published:2008-12 Issue:12 Volume:28 Page:1483-1494
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Farid Nagy A,Small David S,Payne Christopher D,Jakubowski Joseph A,Brandt John T,Li Ying G,Ernest C. Steven,Salazar Daniel E,Konkoy Christopher S,Winters Kenneth J

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1592/phco.28.12.1483/fullpdf

Reference42 articles.

1. Biology and Pharmacology of the Platelet P2Y12 Receptor

2. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270

3. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties

4. ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article

5. Prasugrel: A Novel Thienopyridine Antiplatelet Agent. A Review of Preclinical and Clinical Studies and the Mechanistic Basis for Its Distinct Antiplatelet Profile

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

2. Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy;Minerva Cardiology and Angiology;2023-10

3. Pharmacokinetics and Pharmacodynamics of Approved and Investigational P2Y12 Receptor Antagonists;Clinical Pharmacokinetics;2020-02-13

4. Antiplatelet Effect of a Pulaimab [Anti-GPIIb/IIIa F(ab)2 Injection] Evaluated by a Population Pharmacokinetic-pharmacodynamic Model;Current Drug Metabolism;2020-01-23

5. Prescription switching: Rationales and risks;International Journal of Clinical Practice;2019-10-07